Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Levofloxacin × Classical hematology × Clear all

Phase

Phase 4 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4 Lymphoid 3 Dermatologic 2 Thoracic 1 Myeloid 1 Gynecologic 1 Genitourinary 1 Classical hematology 1 CNS 1 Breast 1

Conditions

Neoplasms 1 Febrile Neutropenia 1

Interventions

Epoetin Alfa 26 Darbepoetin alfa 10 Dalteparin 8 Rivaroxaban 7 Cytarabine 7 Etoposide 6 apixaban 5 Idarubicin 5 Heparin, Low-Molecular-Weight 5 Daunorubicin 5 emicizumab 4 Tinzaparin 4 Thioguanine 4 Mitoxantrone 4 Methotrexate 4 Enoxaparin 4 Cyclophosphamide 4 pegfilgrastim 3 epoetin beta 3 Saline Solution 3 Radiotherapy 3 Hydrocortisone 3 Granulocyte Colony-Stimulating Factor 3 Erythropoietin 3 Dexamethasone 3 Aspirin 3 Asparaginase 3 oprelvekin 2 luspatercept 2 hetrombopag 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03003273 2019-02-01

DALFEN

All India Institute of Medical Sciences

Phase 3 Terminated

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡